Srinivas Veerla

9PUBLICATIONS
40CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Microfluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 16, 2026
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer.

Helen R Davies, Daniella Black, Anders Kvist

|Nov 10, 2025
Stand-alone Transcriptional Immune Response Prediction in Primary Triple-Negative Breast Cancer.

Suze Roostee, Fredrika Killander, Hani Saghir

|Apr 14, 2025
Global Transcriptional Complexity of Estrogen Receptor-Low Positive Breast Cancers in the Prospective Swedish Population-Based SCAN-B Cohort.

Siker Kimbung, Srinivas Veerla, Kadum Muhammad

|Mar 29, 2025
The DNA methylation landscape of primary triple-negative breast cancer.

Mattias Aine, Deborah F Nacer, Elsa Arbajian

|Mar 05, 2025
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer.

Lennart Hohmann, Kristin Sigurjonsdottir, Ana Bosch Campos

|Jan 03, 2025
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters.

Sofia Westbom-Fremer, Lena Tran, Anna Ebbesson

Pageof 2